References in periodicals archive ?
While most Americans have heard of older tests for lung cancer, such as chest x-ray (80%), 74% MRI or CT scan, but only one-fourth of the population (26%) know about a new and effective test, autofluorescence bronchoscopy.
Autofluorescence bronchoscopy is a new technology developed by Canadian company Xillix Technologies Corp.
The advantage of autofluorescence bronchoscopy is that it enables the physician to get right into the lung and illuminate areas of risk.